How to write a patient portal message so your doctor responds
Is your doctor leaving you on read? A new study suggests that the secret to getting your provider…
Mass General Brigham Medicare Advantage plan drops Dana-Farber
Eldon Clingan has had the same cancer specialist at Dana-Farber Cancer Institute for more than two decades. He…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
The new GLP-1 weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
California wants to ban AI therapists as thousands turn to chatbots for mental healthcare
California lawmakers are pushing to stop AI from being used as a full-on therapist as interest in chatbot-based…
CT health care system sends people home with new technology
Hartford HealthCare president and CEO Jeffrey Flaks is well-known for working to spread healthcare across the state. During…
Healthcare workers in CT say they face assault and abuse
Tiffani Nodgren remembers the patient lunging at her and the next thing she knew she was unconscious on…
Employees laid off at CHC demand transparency and communication
Employees laid off at Community Health Centers demand transparency and communication from management BURLINGTON, Vt. — Employees laid…
Why health insurance costs so much: ‘Out of Pocket, Out of Reach’
More than 150 million Americans get their health insurance from a job, making it the primary way people…
Bryan Johnson’s diagnosis shines light on hard-to-detect disease
Longevity entrepreneur Bryan Johnson shared some bad news on social media recently. “I have an autoimmune disease. My…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…